The holidays are a time to relax and spend time with friends and family. Usually, the relaxing part includes ample amounts of beer, wine and eggnog. But now, with cannabis fully legal nationwide, pot may become a bigger part of the holiday revelry. And should that turn out to be the case, cannabis producers will be the main beneficiaries.

Many types of stocks do well during the holidays, most notably retailers, shipping companies, and credit card makers. These companies typically get a boost during the winter because of strong retail sales. Wine is another category that gets a boost in December, as it is the type of alcohol most commonly given as a gift.

As Canada edged ever closer this year to making it legal for any adult to buy marijuana, Dr. Hance Clarke noticed a surprising phenomenon.

At his Toronto pain clinic, Clarke encountered more and more people eager for him to prescribe medical cannabis, though they could soon buy the drug without anyone’s approval. The trend has continued and today he estimates that 15 of every 20 of his patients seek pot as a treatment.

Logic suggests the newly legalized recreational weed business — which makes purchasing cannabis about as difficult as ordering a bestseller online — would render the rest of the market irrelevant.

Any cursory look at the markets would reveal that 2018 wasn’t the best year for investors. That goes for speculative assets as well, including marijuana stocks. Although going green has proven net positive for the early birds, the sector tanked heavily during the October selloff. Still, I wouldn’t drop them from your list of stocks to buy just yet.

Despite their well-publicized fall from grace, several marijuana stocks have stabilized from their severe correction. While that’s no guarantee that the industry is done spilling blood, the deflated prices will almost certainly attract speculators. Should enough risk-takers enter the arena, publicly traded cannabis companies will jump higher, even if it’s only a temporary swing.

Gingerbread men are a seasonal staple but the spiced treats made by Vanessa Labrecque this year will be special: they'll be infused with cannabis.

The avid baker says she'll be whipping up a batch of herb-spiked cookies for a special Christmas edition of her cooking-with-cannabis class in honour of Canada's first festive season post-legalization.

The popular cookie is a good candidate for such non-traditional experimentation, she says, because they are relatively easy to make and the myriad of spices help mask the flavour of weed.

Cannabis penny stocks had a rough start to the week, but this morning it seems to have turned all around!

The major cannabis stocks are also trading green today on both US and Canadian exchanges, which may be the reason for the upswing in penny stocks. 

Today, we’ll take a closer look at the penny stocks trending on the TSXV this morning.

The marijuana industry has had an historic, if not odd, year.

On one hand, the legal cannabis industry gained legitimacy with Canada choosing to legalize recreational marijuana in October. Although it's going to take a few years before growers are operating at peak potential, the legal weed industry could easily generate in the neighborhood of $5 billion in added annual sales by early next decade.

The pullback in the stock prices of Canada’s top cannabis stocks has investors wondering which companies are best positioned to deliver strong results in 2019 and beyond.

Let’s take a look at Canopy Growth (TSX:WEED)(NYSE:CGC) to see if it deserves to be on your marijuana stock buy list.

Investors looking for exposure to the burgeoning U.S. cannabis sector may not have to go north much longer.

With lawmakers likely to vote to legalize hemp soon, cannabis company Vertical Cos. plans to spin off its hemp assets into a separate company called Vertical Wellness and list it on the Nasdaq. Other companies that extract cannabidiol, known as CBD, from hemp are poised to follow suit to other U.S. exchanges.

“We feel that with the farm bill passing, it opens up the pathway to a formal listing on a U.S. exchange like Nasdaq,” said Smoke Wallin, president of distribution, sales and marketing at the Agoura Hills, California-based Vertical. The company cultivates and sells cannabis products in four U.S. states.

Without warning, his baby had stopped breathing, and he frantically performed CPR while his friend James Gallagher called 911.

Years later, the men still become emotional remembering that day. Boissonneault learned that his daughter had a rare disorder that caused epilepsy, and when pharmaceutical medications failed to cure her seizures, he turned to CBD oil, a non-psychoactive substance in marijuana.

Q1: I’ve got MS. What’s cannabis for?

Lawrence is certainly not alone. An estimated one in every 385 Canadians are living with multiple sclerosis (MS), which both Statistics Canada and the MS Society of Canada report is one of the highest incidence in the world. An autoimmune disease of the central nervous system, MS inflames and damages the myelin sheath that protects the nerves, disrupting the signals transmitted along them.